{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:42:31Z","timestamp":1777506151160,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00432-009-0574-8","type":"journal-article","created":{"date-parts":[[2009,3,31]],"date-time":"2009-03-31T06:00:02Z","timestamp":1238479202000},"page":"1331-1339","source":"Crossref","is-referenced-by-count":88,"title":["Overexpression of Grb2\/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance"],"prefix":"10.1007","volume":"135","author":[{"given":"Guan Zhen","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,1]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejca.2005.07.034","volume":"42","author":"R Bianco","year":"2006","unstructured":"Bianco R, Melisi D, Ciardiello F et al (2006) Key cancer cell signal transduction pathways as therapeutic targets. Eur J Cancer 42:290\u2013294. doi: 10.1016\/j.ejca.2005.07.034","journal-title":"Eur J Cancer"},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-2559.1998.00376.x","volume":"32","author":"P Blok","year":"1998","unstructured":"Blok P, Craanen ME, Dekker W et al (1998) No evidence for c-erbB-2 overexpression in gastric carcinogenesis. Histopathology 32:335\u2013339. doi: 10.1046\/j.1365-2559.1998.00376.x","journal-title":"Histopathology"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3800525","volume":"19","author":"S Bose","year":"2006","unstructured":"Bose S, Chandran S, Mirocha JM et al (2006) The Akt pathway in human breast cancer: a tissue-array-based analysis. Mod Pathol 19:238\u2013245. doi: 10.1038\/modpathol.3800525","journal-title":"Mod Pathol"},{"key":"574_CR4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0092-8674(91)90639-G","volume":"64","author":"LC Cantley","year":"1991","unstructured":"Cantley LC, Auger KR, Carpenter C et al (1991) Oncogenes and signal transduction. Cell 64:281\u2013302. doi: 10.1016\/0092-8674(91)90639-G","journal-title":"Cell"},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-5793(95)00578-W","volume":"369","author":"P Chardin","year":"1995","unstructured":"Chardin P, Cussac D, Maignan S et al (1995) The Grb2 adaptor. FEBS Lett 369:47\u201351. doi: 10.1016\/0014-5793(95)00578-W","journal-title":"FEBS Lett"},{"key":"574_CR6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0092-8674(00)81702-X","volume":"95","author":"AM Cheng","year":"1998","unstructured":"Cheng AM, Saxton TM, Sakai R et al (1998) Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95:793\u2013803. doi: 10.1016\/S0092-8674(00)81702-X","journal-title":"Cell"},{"key":"574_CR7","first-page":"371","volume":"12","author":"C D\u2019Ambrosio","year":"1996","unstructured":"D\u2019Ambrosio C, Hongo A, Li S et al (1996) The role of Grb2 in the growth and transformation of mouse embryo cells. Oncogene 12:371\u2013378","journal-title":"Oncogene"},{"key":"574_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.cad.0000185180.72604.ac","volume":"17","author":"PG Dharmawardana","year":"2006","unstructured":"Dharmawardana PG, Peruzzi B, Giubellino A et al (2006) Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs 17:13\u201320. doi: 10.1097\/01.cad.0000185180.72604.ac","journal-title":"Anticancer Drugs"},{"key":"574_CR9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-5793(94)80346-3","volume":"338","author":"J Downward","year":"1994","unstructured":"Downward J (1994) The GRB2\/Sem-5 adaptor protein. FEBS Lett 338:113\u2013117. doi: 10.1016\/0014-5793(94)80346-3","journal-title":"FEBS Lett"},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF03036740","volume":"8","author":"A Ghaderi","year":"2002","unstructured":"Ghaderi A, Vasei M, Maleck-Hosseini SA et al (2002) The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma. Pathol Oncol Res 8:252\u2013256","journal-title":"Pathol Oncol Res"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ijc.11599","volume":"108","author":"E Half","year":"2004","unstructured":"Half E, Broaddus R, Danenberg KD et al (2004) HER-2 receptor expression, localization, and activation in colorectal cancer cell lines and human tumors. Int J Cancer 108:540\u2013548. doi: 10.1002\/ijc.11599","journal-title":"Int J Cancer"},{"key":"574_CR12","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1038\/sj.onc.1206742","volume":"22","author":"I Ischenko","year":"2003","unstructured":"Ischenko I, Petrenko O, Gu H et al (2003) Scaffolding protein Gab2 mediates fibroblast transformation by the SEA tyrosine kinase. Oncogene 22:6311\u20136318. doi: 10.1038\/sj.onc.1206742","journal-title":"Oncogene"},{"key":"574_CR13","first-page":"3601","volume":"9","author":"PW Janes","year":"1994","unstructured":"Janes PW, Daly RJ, deFazio A et al (1994) Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3601\u20133608","journal-title":"Oncogene"},{"key":"574_CR14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00019606-200109000-00001","volume":"10","author":"S Kaptain","year":"2001","unstructured":"Kaptain S, Tan LK, Chen B (2001) Her-2\/neu and breast cancer. Diagn Mol Pathol 10:139\u2013152. doi: 10.1097\/00019606-200109000-00001","journal-title":"Diagn Mol Pathol"},{"key":"574_CR15","first-page":"67","volume":"12","author":"J Leng","year":"1997","unstructured":"Leng J, Lang J, Shen K et al (1997) Overexpression of p53, EGFR, c-erbB2 and c-erbB3 in endometrioid carcinoma of the ovary. Chin Med Sci J 12:67\u201370","journal-title":"Chin Med Sci J"},{"key":"574_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0092-8674(92)90167-B","volume":"70","author":"EJ Lowenstein","year":"1992","unstructured":"Lowenstein EJ, Daly RJ, Batzer AG et al (1992) The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431\u2013442. doi: 10.1016\/0092-8674(92)90167-B","journal-title":"Cell"},{"key":"574_CR17","doi-asserted-by":"crossref","unstructured":"MacFarlane R, Speers C, Masoudi H et al (2008) Molecular changes in the primary breast cancer versus the relapsed\/metastatic lesion from a large population-based database and tissue microarray series. J Clin Oncol 26:abstr 1000","DOI":"10.1200\/jco.2008.26.15_suppl.1000"},{"key":"574_CR18","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0748-7983(97)90669-7","volume":"23","author":"P McCulloch","year":"1997","unstructured":"McCulloch P, Taggart T, Ochiai A et al (1997) c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 23:304\u2013309. doi: 10.1016\/S0748-7983(97)90669-7","journal-title":"Eur J Surg Oncol"},{"key":"574_CR19","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","volume":"26","author":"MM Moasser","year":"2007","unstructured":"Moasser MM (2007) The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis. Oncogene 26:6469\u20136487. doi: 10.1038\/sj.onc.1210477","journal-title":"Oncogene"},{"key":"574_CR20","first-page":"349","volume":"115","author":"K Motojima","year":"1994","unstructured":"Motojima K, Furui J, Kohara N et al (1994) erbB-2 Expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Surgery 115:349\u2013354","journal-title":"Surgery"},{"key":"574_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/172460080101600405","volume":"16","author":"CT Oshima","year":"2001","unstructured":"Oshima CT, Lanzoni VP, Iriya K et al (2001) C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis. Int J Biol Markers 16:250\u2013254","journal-title":"Int J Biol Markers"},{"key":"574_CR22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/106689690201000402","volume":"10","author":"J Pinto-de-Sousa","year":"2002","unstructured":"Pinto-de-Sousa J, David L, Almeida R et al (2002) c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma. Int J Surg Pathol 10:247\u2013256. doi: 10.1177\/106689690201000402","journal-title":"Int J Surg Pathol"},{"key":"574_CR23","first-page":"308","volume":"54","author":"S Potrc","year":"2007","unstructured":"Potrc S, Gadiijev E, Hajdinjak T et al (2007) Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer. Hepatogastroenterology 54:308\u2013314","journal-title":"Hepatogastroenterology"},{"issue":"Suppl 1","key":"574_CR24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10120-002-0203-6","volume":"5","author":"DM Roder","year":"2002","unstructured":"Roder DM (2002) The epidemiology of gastric cancer. Gastric Cancer 5(Suppl 1):5\u201311. doi: 10.1007\/s10120-002-0203-6","journal-title":"Gastric Cancer"},{"key":"574_CR25","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1038\/sj.onc.1205261","volume":"21","author":"C Saucier","year":"2002","unstructured":"Saucier C, Papavasiliou V, Palazzo A et al (2002) Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis. Oncogene 21:1800\u20131811. doi: 10.1038\/sj.onc.1205261","journal-title":"Oncogene"},{"key":"574_CR26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0896-6273(92)90177-F","volume":"9","author":"J Schlessinger","year":"1992","unstructured":"Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9:383\u2013391. doi: 10.1016\/0896-6273(92)90177-F","journal-title":"Neuron"},{"key":"574_CR27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000227494","volume":"52","author":"T Suzuki","year":"1995","unstructured":"Suzuki T, Tsuda T, Haruma K et al (1995) Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2. Oncology 52:385\u2013391","journal-title":"Oncology"},{"key":"574_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.2930490402","volume":"49","author":"M Tateishi","year":"1992","unstructured":"Tateishi M, Toda T, Minamisono Y et al (1992) Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. J Surg Oncol 49:209\u2013212. doi: 10.1002\/jso.2930490402","journal-title":"J Surg Oncol"},{"key":"574_CR29","first-page":"2625","volume":"62","author":"A Varis","year":"2002","unstructured":"Varis A, Wolf M, Monni O et al (2002) Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62:2625\u20132629","journal-title":"Cancer Res"},{"key":"574_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<195::AID-PATH901>3.0.CO;2-Y","volume":"183","author":"BS Verbeek","year":"1997","unstructured":"Verbeek BS, Adriaansen-Slot SS, Rijksen G et al (1997) Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J Pathol 183:195\u2013203. doi: 10.1002\/(SICI)1096-9896(199710)183:2<195::AID-PATH901>3.0.CO;2-Y","journal-title":"J Pathol"},{"key":"574_CR31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/172460080401900403","volume":"19","author":"FJ Vizoso","year":"2004","unstructured":"Vizoso FJ, Corte MD, Alvarez A et al (2004) Membranous levels of c-erbB-2 oncoprotein in gastric cancer: their relationship with clinicopathological parameters and their prognostic significance. Int J Biol Markers 19:268\u2013274","journal-title":"Int J Biol Markers"},{"key":"574_CR32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/1568009053765771","volume":"5","author":"MW Wiedmann","year":"2005","unstructured":"Wiedmann MW, Caca K (2005) Molecularly targeted therapy for gastrointestinal cancer. Curr Cancer Drug Targets 5:171\u2013193. doi: 10.2174\/1568009053765771","journal-title":"Curr Cancer Drug Targets"},{"key":"574_CR33","first-page":"65","volume":"15","author":"T Yano","year":"2006","unstructured":"Yano T, Doi T, Ohtsu A et al (2006) Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer. Oncol Rep 15:65\u201371","journal-title":"Oncol Rep"},{"key":"574_CR34","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/jm980388x","volume":"42","author":"ZJ Yao","year":"1999","unstructured":"Yao ZJ, King CR, Cao T et al (1999) Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. J Med Chem 42:25\u201335. doi: 10.1021\/jm980388x","journal-title":"J Med Chem"},{"key":"574_CR35","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4","volume":"88","author":"SS Yip","year":"2000","unstructured":"Yip SS, Crew AJ, Gee JM et al (2000) Up-regulation of the protein tyrosine phosphatase SHP-1 in human breast cancer and correlation with GRB2 expression. Int J Cancer 88:363\u2013368. doi: 10.1002\/1097-0215(20001101)88:3<363::AID-IJC7>3.0.CO;2-4","journal-title":"Int J Cancer"},{"key":"574_CR36","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1038\/sj.bjc.6603459","volume":"95","author":"H Yokoyama","year":"2006","unstructured":"Yokoyama H, Ikehara Y, Kodera Y et al (2006) Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. Br J Cancer 95:1504\u20131513. doi: 10.1038\/sj.bjc.6603459","journal-title":"Br J Cancer"},{"key":"574_CR37","doi-asserted-by":"crossref","unstructured":"Yonemura Y, Ninomiya I, Ohoyama S, et al (1991) Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer 67:2914\u20132918. doi: 10.1002\/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>3.0.CO;2-G","DOI":"10.1002\/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>3.0.CO;2-G"},{"key":"574_CR38","first-page":"1191","volume":"19","author":"GZ Yu","year":"2008","unstructured":"Yu GZ, Chen Y, Long YQ et al (2008) New insight into the key proteins and pathways involved in the metastasis of colorectal carcinoma. Oncol Rep 19:1191\u20131204","journal-title":"Oncol Rep"},{"key":"574_CR39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10585-004-2051-8","volume":"21","author":"XP Zang","year":"2004","unstructured":"Zang XP, Siwak DR, Nguyen TX et al (2004) KGF-induced motility of breast cancer cells is dependent on Grb2 and Erk1,2. Clin Exp Metastasis 21:437\u2013443. doi: 10.1007\/s10585-004-2051-8","journal-title":"Clin Exp Metastasis"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0574-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-009-0574-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-009-0574-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:39:51Z","timestamp":1559083191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-009-0574-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s00432-009-0574-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}